Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 9Observational 1

Sponsor

Cancer Type

Other solid neoplasm 4Thoracic 3Breast 3Gastrointestinal 2CNS 2Head & Neck 1Gynecologic 1Dermatologic 1

Conditions

Melanoma 1

Interventions

Blood Specimen Collection 22Surveys and Questionnaires 19Nivolumab 14Ipilimumab 12pembrolizumab 11Gene Expression Profiling 11Biopsy 10trametinib 9dabrafenib 8Flow Cytometry 8Specimen Handling 7Polymerase Chain Reaction 7Tomography, Optical Coherence 6Therapeutics 6Immunohistochemistry 6Imiquimod 6Amplified Fragment Length Polymorphism Analysis 6Watchful Waiting 5Psychiatric Rehabilitation 5Immunotherapy 5Data Collection 53-ingenyl angelate 5Mohs Surgery 4Microarray Analysis 4Interviews as Topic 4Immunoenzyme Techniques 4Drug Therapy 4Dermoscopy 4sonidegib 3encorafenib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Fluorodeoxyglucose F18 × Dermatologic × Clear all
NCT05645484 2023-02-21

The Prognostic Value of 18F-PFPN PET Imaging in Patients With Malignant Melanoma

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Unknown
100 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡